Tuesday, October 29, 2019

Neuroinflammatory priming to stress is deferentially regulated in male and female rats

Through this research, Fonken et al. were looking to study neuroinflammatory priming, specifically the differences in priming between male and female rats. Despite having a higher prevalence of many stress disorders, these models are frequently studies in males but not females. With the hypothesis that males and females have different inflammatory and priming systems, this could be very damaging toward how women receive medical care and their biology is understood. 

This was studied through a series of eight experiments stating with if LPS sickness behaviors are impacted by prior stress. In this part of the experiment, other sexes reacted similarly to the stress priming. However, there were certainly differences between the sexes found, too. It was found that hippocampal microglia were primed by stress in males, but not females. It was also found that females had higher expression of CD200R and lower expression of CD200L than males.

There were also some very interesting results related to CORT. Female serum CORT levels stayed higher for longer, and which may have implications to their lack of microglia priming. This researched demonstrated that there are differences in how males and females prime, which is both important for further research and fascinating.

I enjoyed that the researchers found it important to examine the difference between sexes which studying neurological conditions. I disliked the layout of the paper, and how figures were not clearly correlated with experiments, making it sometimes were challenging to understand that was being demonstrated and which of the many experiments the data related to. However, I look forward to reading further research inspired both by these findings and this line of thinking. 

Monday, October 28, 2019

Sex Differences in Neuroinflammatory Response


            I think this article really shows exactly how much information has been lost in only studying male animal models of disease. Here, the authors show that the pathway mediating stress in the two different sexes are different, and that females have a markedly different biochemical reaction in their brains in response to stress. This could potentially have implications for pharmacological treatment of stress-related psychiatric disorders, seeing as there would be a new mechanism of action to be targeted. For that reason, I think this paper is very important and worth highlighting as evidence for why studies including both sexes are absolutely necessary.
            The authors clearly outlined all their experiments, which in turn made it easier to analyse their results, and I appreciated that. One thing that I was a bit confused about was the number of groups – it was not always so clear in each experiment how many groups there were and exactly who was getting what. I saw in their methods that they had a very large number of rats that they used in total (258), and so a clearer breakdown of the groups would have been helpful. Seeing as there were multiple compound effects that the authors were testing, it would have been better to do some sort of table to clearly define which treatments certain groups were getting.
            Overall, I liked that the paper focused on the differences between males and females, and that the authors dedicated a large number of experiments to not only prove that there was a difference, but also to try and elucidate a mechanism to explain why. In looking at the behavior, the male and female animals appeared similar in response, which is probably one of the reasons why a more detailed look at the differences between the sexes was never attempted. If they look the same and act the same, why wouldn’t people assume that they are the same? But this paper actually delves into the mechanism behind the neuroinflammatory response to stress, and I think it was a very well done experiment that should inspire further experiments to analyse the cellular differences in male and female response to other paradigms, such as chronic stress or chronic fatigue.

stress-induced neuroinflammatory


Within the article “Stress-induced neuroinflammatory priming is time of day dependent”, researchers studied whether stress-induced neuroinflammatory priming is regulated by the circadian system. In addition, scientists studied whether or not microglia are differentially sensitized to stress in the light versus the dark as well as whether these microglia are altered by corticosterone treatment. Lastly, the researchers wanted to know if stress-induced corticosterone release depended on the time of the day as well.

I found this article to be very interesting and learned a lot of new things regarding the role glucocorticoids have on the suppression on inflammation and potentiating the inflammatory response. I liked how they included the reversal light/dark cycle in their experiment as well. However, I was a bit confused and couldn’t seem to find the results for that part of the experiment? I also didn’t quite understand the Zeitgeber time and what they meant by ZT3-ZT15 and ZT7 to ZT19. Within the figures and experimental design, I only saw ZT16 and ZT6 so I was mixed up a bit by the different times. The figures were overall clear in illustrating the gene expression during each stress-induced phase (TNF, IL), however, I didn’t quite understand what the administration of LPS did exactly.

I also found the experiment on microglia and corticosterone to be interesting. I am wondering why the corticosterone concentrations after the stressor did not differ at the two different times. Those results didn’t unveil the mechanism behind the timing of neuroinflammation. I was also surprised that they didn’t find any effect on MHCII expression in microglia after corticosterone treatment. To add on, they included information on nocturnal rodents and how they were more susceptible to the effects of stress during the light (inactive phase) and am curious as to what are the differences in circadian systems. The paper discussed how previous studies used a different severity in stress. I think it would be interesting to test these severity levels together and see how different stressors impact the circadian system. Lastly, I liked how they included limitations as well as possible reasons as to why certain results did not agree.

Stress-induced neuroinflammatory priming is time of day dependent

This study sought to establish whether diurnal timing of a stressor affects neuroinflammatory priming of microglia. Previously, it was already known that the time of day which an inflammatory challenge occurs affects stress-induced neuroinflammatory priming, but the effect of timing of the stressor had not been established.

The researchers made a few notable findings including the fact that the timing of the stressor did, indeed, influence neuroinflammatory priming, the inflammatory response of microglia was modulated by stressor timing, glucocorticoids down-regulate genes responsible for microglia inhibition, and the magnitude of change in corticosterone levels are enhanced when the stressor is presented during the light phase, but not the dark phase.

Overall, I was pleased with the execution of this study. One question I had was why the time point of three hours after LPS injection was used to collect hippocampal tissue, as I don't believe a reason for this time point was stated. Might it be possible that cytokine levels following this three-hour window do not accurately represent the inflammatory response? Another qualm I had was that only one time point in each phase (light or dark) was used in the timing of the stressor. Although they already had 8 groups, I think it would have been interesting to see how stressors at other time points would affect neuroinflammatory response.

I think that the researchers did a pretty good job of pointing out the nuances in their own study as well. For example, the authors pointed out that although there were no significant differences in corticosterone concentrations between stressors during the light vs dark phase, it is important to note that basal corticosterone concentrations were lower in the light phase as compared to the dark phase. Thus, the difference between baseline corticosterone levels and those produced after the stressors was larger when the stressor was presented during the light phase.

Lastly, I also think that the reasons for which this research is relevant in humans are notable. As the authors point out, individuals who work shifts during the "inactive phase" may experience heightened neuroinflammatory responses and be more at risk for mood disorders. This has many implications in considering how changes can be made to lesson the deleterious effects of shift work.

Male/female neuroimflammatory priming to stress

This paper addresses a very important topic regarding sex prevalence in psychiatric diseases. Although females are more likely to suffer from anxiety and depression than males, most models used to study these disorders are male. Furthermore, this research is important since there is no miracle cure for depression as well as many related psychiatric disorders. Understanding what mechanisms are activated in immune responses in males and females may lead to a clues underlying the neural basis of mood disorders, as well as a variety of other neurological diseases. 
Although females showed an overall reduction in social exploratory behavior compared to males in response to stress followed by LPS injection, I was suprised to see no interaction of sex with time, stress, or immune challenge. I did not expect male and female rats to have a comparable response to the experimental treatments due to different microglial activation states and morphology between males and females. On a similar note, I was suprised to learrn that there was no effect of sex on hippocampal cytokine expression. Since microglia are responsible for the release of cytokines, this may indicate that microglia function similarly in males and females in response to stress. However, the findings reveal that that prior stress had no effect on levels of cytokine expression in the microglia of females whereas prior stress primed male microglia to potentiate the cytokine response.
On the other hand, it was interesting to note that stress similarly reduces the phagocytic ability of microglia in males and females as from prior research, I know that an increase in testosterone disproportionately effects microglial phagocytosis of astrocytes in the amygdala. I wonder whether the effects of stress would be the same had microglial phagocytosis been evaluated in stress-induced rats during their early stages of development such as at P4, for example, when the testosterone difference between males and females is the greatest.
I found it surprising that while microglia from post-stress male rats were more reactive, microglia from female rats were unaffected by stress exposure. Low CORT levels are likely not the cause of this lack of priming in females as L-1β mRNA expression was unaffected and moreover, IL-6 mRNA expression was suppressed in females 7 days post-stress at the supposed baseline of CORT. Because the CORT levels in females were highly variable across the females 3 days post-stress, I wonder whether evaluating cytokine levels 7 days post-stress controlled for the differences in the rates of CORT decrease within females. Overall, I think that several experiments performed in this study could benefit from evaluating LPS and CORT responses at several time points. 
Regardless, because microglial priming was differentially affected by CORT in male and female rats, I think this study does a good job of suggesting a link between neuroinflammatory responses in microglia and glucocorticoids which could be responsible for the sex differences in psychiatric disorder prevalence. I think it would be useful to perform similar experiments with different types of induced stress as males and females may respond differently to other stressors and it would indicate whether all stress can be generalized to the observed neuroinflammatory responses in this study.

Stress Induced Neuroinflammatory Priming is Time of Day Dependent


This week I read the article title Stress-Induced neuroinflammatory priming is time of day dependent. In general, the article examined the differences between neuroinflammation between rats exposed to a stressor during the light cycle and animals exposed to a stressor during the dark cycle. Overall, I thought that the experiment did a good job of using multiple measures to assess the effects of circadian rhythm on neuroinflammation.

The introduction/background section in my opinion could have been more detailed and could specifically have included more information included later in the discussion. For example, the discussion section included additional information on what the actual proteins measured on the microglia were responsible for, and how measuring their RNA was relevant to microglial activation. If this had been included in the introduction it would have made interpreting those results easier the first time around. However, the more general important aspects were clearly introduced. The background section on glucocorticoids was particularly interesting to me because of its relevance to my mock grant proposal methods. I had initially considered using glucocorticoids as a treatment to reduce neuroinflammation, however this article discussed that it could actually potentiate inflammatory responses which could conflict results. The overall effects that circadian rhythm had on the brain also made me think about the microglial alterations and depressive symptoms article that we read, where behavioral tests were performed during the dark cycle which I though could cause altered results due to the disrupted circadian rhythm.

As is the case with most of the articles we have read, all the animals used were male which we have already discussed but is still worth bringing up. I was unsure what the study meant when it said that the LPS dose resulted in a sub-threshold hippocampal pro-inflammatory response. As neuroinflammation is what was being measured I would assume that the inflammatory response should be above threshold, so this confused me a little. Additionally, the use of a reverse light dark cycle is definitively a convenient way to line up the experimental treatment and tissue collection, however I was curious as to how long the rats were given to adjust to this reversal. I was also curious as to how long it takes corticosterone levels in the blood to change, as in experiment four the blood samples were collected immediately after IS or HCC treatment so results may have been different if the timing was different.

The results clearly showed that neuroinflammation priming was influenced by the time of day that the stressor was applied. This was seen in IL-B1 response and gene expression, and in IL-6 gene expression. However, the experiments aimed at determining a mechanism did not really find significant differences. I was surprised that there was not difference in the phenotype of microglia isolated at different times, and that there was no significant difference in the corticosterone concentration at the different times. These seem to be the most obvious mechanisms for the differences in neuroinflammation priming so I would have expected there to be significant differences.

Neuroinflammatory priming to stress is differentially regulated in male and female rats

It’s been known that elevated corticosterone signaling and activated microglia result in increased neuroinflammatory responses after stress exposure in rodents, but this particular study wanted to further examine the role of sex differences in this process. I think this is a well designed paper with decently thought through experiments. I believe they are asking the right questions, but not testing it correctly.  If you are measuring sex differences in response to stress, you must take into consideration the various stages of the estrous cycle. Were all the females in the same estrous stage? How did that impact their response to stress? Using an inescapable stress tail shock paradigm is common but also has its drawbacks. One of the many challenges is learned helplessness which is hard to compensate for. Is it possible that females are more persistent while males feel helpless in the situation? I know that any inescapable stress paradigm would make me feel pretty helpless. This study should use other methods of inducing stress and see how results compare. Things like a forced-swim should be avoided because that seems highly correlated with learned helplessness. Other confounding variables like sleep can also impact results. Overall, this paper does address very valid points and highlights the importance of sex differences in stress, but I think their approach and methods need a bit of work. 

Saturday, October 26, 2019

Neuroinflammatory priming to stress is differentially regulated in male and female rats

Fonken et al. aimed to study the mechanisms behind neuroinflammatory priming and to see there were differences between males and females. Most studies on this topic have been done on males even though females have higher incidences of stress related disorders and have more prolonged behavioral and physiological responses to stress. It has been shown that exposure to stress can enhance neuroinflammatory responses when met with an immune challenge in males through enhanced corticosterone signaling and activated microglia, so Fonken et al. wanted to further test this in females.
Fonken et al. studied their hypothesis through several experiments. First, they tested if LPS-induced sickness behaviors are exaggerated by prior stress exposure in male and female rats. They found reduced sucrose preference and social exploration in both male and female rats that were exposed to inescapable stress as compared to those not exposed to stress. To further study the inflammatory responses as a result of stress exposure, they found both sexes have similar pro-inflammatory responses. However, there were a few differences. Females had elevated CD200R and reduced CD200L expression compared to males, and females only who had undergone stress showed potentiated serum IL-Iß responses to LSP. The authors further tested if hippocampal microglia were primed by prior stress and found that it is for males but not for females. This is because females had no differences in IL-1b and IL-6 mRNA expression in microglia following stress or home cage treatment while males do. To see if microglia in females activate in a different way, they measured phagocytic capacity of microglia in both males and females. They found that less microglia from stressed compared to home cage rats phagocytosed in both males and females. The authors then investigated differences between corticosterone responses after stress in males and females and measured corticosterone levels up to 4 weeks after stress. Female serum corticosterone levels was increased for a loner duration following stress than males. When corticosterone levels returned to baseline, the microglia from females did not exhibit primed behaviors which may be due to the increase in corticosterone. They further tested if corticosterone is sufficient to prime neuroinflammatory responses in males and females. It induces priming in vivo in females and males, but not ex vivo in female rats. Lastly, Fonken et al. tested if glucocorticoids are sufficient to prime microglia in males and females. Glucocorticoid expression didn’t change in males after stress but was down regulated in females.
These results show distinct differences in priming mechanisms between males and females. There were drawbacks in this study, however. Only inescapable tail shock was used as a stressor. Other types of stressors could provoke differences in neuroinflammatory priming. Also, the estrous cycle in females may have affected the stress response and neuroinflammatory activation. More studies can be done to explore different types of stressors and to measure neuroinflammatory activation at different stages of the estrous cycle.
I liked how this paper used females in this study because it is important for sex differences to be addressed when studying neuropsychiatric disorders. Females may show different symptoms than males in stress-related disorders and have different underlying mechanisms behind them.Research that focuses on both sexes can provide more insight on make treatments for neuropsychiatric disorders geared towards females and treatments geared towards males. What I disliked about this paper the amount of experiments that was done and was the figures placed at the end of the paper. It was sometimes hard to follow and connect results from one study to another. Overall, I would like to see more studies that use diverse models to study neuropsychiatric disorders and hope to see more novel treatments for them in the future.

Monday, October 7, 2019

Journal Club 3

This study investigates the link between sickness behavior in a liver inflammation mouse model, the gut microbiome, and the modulatory role of probiotics. The researchers found that the probiotic treatment in the inflammatory mice reduced sickness behavior, microglial activation, and inflammatory markers (like TNF-a).

Right off the bat, the part that stuck with me the most in this paper is the point in the discussion saying “VSL#3 treatment did not significantly alter the gut microbiota, suggesting that the effects of VSL#3 on behavior are independent of overt changes in the gut microbiome.” This seems contrary to everything I had assumed about the gut microbiota, and I am wondering if this is a topic in this field of research with evidence supporting both sides, that has yet to be fully confirmed or denied. Following previous research about the links between behavior and gut microbiome composition (like in the case of mood disorders), I assumed that colonizing the gut with beneficial probiotics such as VSL#3 would improve/diversify microbiome composition. However, maybe I misunderstand the current research, and perhaps probiotics have their affect on behavior by modulating other mechanisms (like cytokine release), rather than microbiome composition alone, which is something that this study has provided support for.

Additionally, I am a little confused about the role that etanercept is playing in their experiments. I understand its role as a TNF inhibitor, but can’t quite grasp how the fact that the etanercept treated mice had the same level of sickness behavior and microglial activation as BDL-VSL#3 mice helps prove their hypothesis. I also don’t believe they included this treatment group in any of their figures, which makes understanding these findings a little more difficult. 


Overall, I thought the figures and various group treatments were all easy enough to follow. I do think this study tried to tackle a lot all at once, which required paying close attention to the legends of each figure to figure out which experiment they were running to obtain that data set. This field of research is so novel and exciting though that I don’t mind spending the extra time to dissect these papers further!